Tirzepatide, a novel medication, is generating significant interest in the medical community as a potential treatment for both managing blood sugar and body composition . This dual-action drug works by activating two separate receptors, GLP-1 and GIP, leading to better blood sugar levels and notable fat loss in testing. While initial data are promi